Annual CFI
-$267.00 K
+$309.00 K+53.65%
31 December 2023
Summary:
Jasper Therapeutics annual cash flow from investing activities is currently -$267.00 thousand, with the most recent change of +$309.00 thousand (+53.65%) on 31 December 2023. During the last 3 years, it has fallen by -$267.00 thousand (-100.00%).JSPR Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$274.00 K
-$117.00 K-74.52%
30 September 2024
Summary:
Jasper Therapeutics quarterly cash flow from investing activities is currently -$274.00 thousand, with the most recent change of -$117.00 thousand (-74.52%) on 30 September 2024. Over the past year, it has dropped by -$274.00 thousand (-100.00%).JSPR Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$686.00 K
-$274.00 K-66.50%
30 September 2024
Summary:
Jasper Therapeutics TTM cash flow from investing activities is currently -$686.00 thousand, with the most recent change of -$274.00 thousand (-66.50%) on 30 September 2024. Over the past year, it has dropped by -$567.00 thousand (-476.47%). JSPR TTM CFI is now -476.47% below its all-time high of -$119.00 thousand, reached on 30 September 2023.JSPR TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JSPR Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +53.6% | -100.0% | -476.5% |
| 3 y3 years | -100.0% | +41.7% | +60.0% |
| 5 y5 years | - | - | - |
JSPR Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | +89.0% | +61.5% | -476.5% | +71.8% | ||
| 5 y | 5 years | +89.0% | +71.5% | -476.5% | +71.8% | ||
| alltime | all time | <-9999.0% | +89.0% | <-9999.0% | +71.5% | -476.5% | +71.8% |
Jasper Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$274.00 K(+74.5%) | -$686.00 K(+66.5%) |
| June 2024 | - | -$157.00 K(+528.0%) | -$412.00 K(+54.9%) |
| Mar 2024 | - | -$25.00 K(-89.1%) | -$266.00 K(-0.4%) |
| Dec 2023 | -$267.00 K(-53.6%) | -$230.00 K(<-9900.0%) | -$267.00 K(+124.4%) |
| Sept 2023 | - | $0.00(-100.0%) | -$119.00 K(-65.1%) |
| June 2023 | - | -$11.00 K(-57.7%) | -$341.00 K(-40.5%) |
| Mar 2023 | - | -$26.00 K(-68.3%) | -$573.00 K(-0.5%) |
| Dec 2022 | -$576.00 K | -$82.00 K(-63.1%) | -$576.00 K(-52.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$222.00 K(-8.6%) | -$1.21 M(-17.1%) |
| June 2022 | - | -$243.00 K(+737.9%) | -$1.45 M(-2.9%) |
| Mar 2022 | - | -$29.00 K(-95.9%) | -$1.50 M(-38.3%) |
| Dec 2021 | -$2.43 M(<-9900.0%) | -$711.00 K(+51.3%) | -$2.43 M(+41.4%) |
| Sept 2021 | - | -$470.00 K(+63.8%) | -$1.72 M(+37.7%) |
| June 2021 | - | -$287.00 K(-70.1%) | -$1.25 M(+29.9%) |
| Mar 2021 | - | -$960.00 K | -$960.00 K |
| Dec 2020 | $0.00 | - | - |
FAQ
- What is Jasper Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Jasper Therapeutics?
- What is Jasper Therapeutics annual CFI year-on-year change?
- What is Jasper Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Jasper Therapeutics?
- What is Jasper Therapeutics quarterly CFI year-on-year change?
- What is Jasper Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Jasper Therapeutics?
- What is Jasper Therapeutics TTM CFI year-on-year change?
What is Jasper Therapeutics annual cash flow from investing activities?
The current annual CFI of JSPR is -$267.00 K
What is the all time high annual CFI for Jasper Therapeutics?
Jasper Therapeutics all-time high annual cash flow from investing activities is $0.00
What is Jasper Therapeutics annual CFI year-on-year change?
Over the past year, JSPR annual cash flow from investing activities has changed by +$309.00 K (+53.65%)
What is Jasper Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of JSPR is -$274.00 K
What is the all time high quarterly CFI for Jasper Therapeutics?
Jasper Therapeutics all-time high quarterly cash flow from investing activities is $0.00
What is Jasper Therapeutics quarterly CFI year-on-year change?
Over the past year, JSPR quarterly cash flow from investing activities has changed by -$274.00 K (-100.00%)
What is Jasper Therapeutics TTM cash flow from investing activities?
The current TTM CFI of JSPR is -$686.00 K
What is the all time high TTM CFI for Jasper Therapeutics?
Jasper Therapeutics all-time high TTM cash flow from investing activities is -$119.00 K
What is Jasper Therapeutics TTM CFI year-on-year change?
Over the past year, JSPR TTM cash flow from investing activities has changed by -$567.00 K (-476.47%)